Cells were activated via crosslinking of NKp30, a natural cytotoxicity receptor whose ligand is expressed on tumor cells [15], and CD18, a member of the heterodimeric integrin lymphocyte function-associated antigen-1 (LFA-1). Here, ITGB2 is linked to neoplasm.